Urinary bladder transplantation in humans - current status and future perspectives.
Journal
Nature reviews. Urology
ISSN: 1759-4820
Titre abrégé: Nat Rev Urol
Pays: England
ID NLM: 101500082
Informations de publication
Date de publication:
20 Sep 2024
20 Sep 2024
Historique:
accepted:
07
08
2024
medline:
21
9
2024
pubmed:
21
9
2024
entrez:
20
9
2024
Statut:
aheadofprint
Résumé
Urinary bladder vascularized allograft transplantation in humans is currently extensively being investigated worldwide, owing to the theoretical potential of this approach as a therapeutic option for individuals with end-stage, non-oncological bladder conditions or congenital bladder pathologies. To date, a successful attempt at urinary bladder autotransplantation was carried out in a heart-beating brain-dead research human donor. The robot-assisted surgical technique was shown to be optimal for performing this procedure, achieving a good performance in terms of both bladder allograft collection as well as vascular, ureterovesical and vesicourethral anastomoses. The urinary bladder vascularized allograft would be an alternative to traditional urinary diversion methods that rely on the use of intestinal segments, potentially avoiding adverse effects associated with these approaches. However, different from ileal urinary diversion, bladder transplantation would require lifelong immune suppression. Clinical trials are in progress to assess the vascularized bladder allograft transplantation technique, as well as the safety of this procedure in oncological and non-oncological indications.
Identifiants
pubmed: 39304780
doi: 10.1038/s41585-024-00935-2
pii: 10.1038/s41585-024-00935-2
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Springer Nature Limited.
Références
Abdelrahim, M. et al. Transplant oncology: an evolving field in cancer care. Cancers 13, 4911 (2021).
pubmed: 34638395
pmcid: 8508383
doi: 10.3390/cancers13194911
Acuna, S. A., Sutradhar, R., Kim, S. J. & Baxter, N. N. Solid organ transplantation in patients with preexisting malignancies in remission: a propensity score matched cohort study. Transplantation 102, 1156–1164 (2018).
pubmed: 29557910
pmcid: 7228636
doi: 10.1097/TP.0000000000002178
Al-Adra, D. P. et al. Pretransplant solid organ malignancy and organ transplant candidacy: a consensus expert opinion statement. Am. J. Transplant. 21, 460–474 (2021).
pubmed: 32969590
doi: 10.1111/ajt.16318
Abecassis, M. et al. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney disease outcomes quality initiative (NKF/KDOQITM) conference. Clin. J. Am. Soc. Nephrol. 3, 471–480 (2008).
pubmed: 18256371
pmcid: 2390948
doi: 10.2215/CJN.05021107
Gutierrez Calzada, J. L. et al. En bloc kidney and bladder transplantation from an anencephalic donor into an adult recipient. J. Urol. 138, 125–126 (1987).
pubmed: 3298688
doi: 10.1016/S0022-5347(17)43017-5
Kato, T. et al. Partial bladder transplantation with en bloc kidney transplant-the first case report of a ‘bladder patch technique’ in a human. Am. J. Transpl. 8, 1060–1063 (2008).
doi: 10.1111/j.1600-6143.2008.02180.x
Ciancio, G. et al. Transplantation of en bloc pediatric kidneys with a partial bladder segment in an adult recipient. Transpl. Int. 22, 350–353 (2009).
pubmed: 19220872
doi: 10.1111/j.1432-2277.2008.00815.x
Sageshima, J. et al. Combined pancreas and en bloc kidney transplantation using a bladder patch technique from very small pediatric donors. Am. J. Transplant. 10, 2168–2172 (2010).
pubmed: 20883550
doi: 10.1111/j.1600-6143.2010.03229.x
Gargollo, P. C. et al. Feasibility study of vascularized composite urinary bladder allograft transplantation in a cadaver model. J. Urol. 206, 115–123 (2021).
pubmed: 33683936
doi: 10.1097/JU.0000000000001699
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT05462561 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT06337942 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04626167 (2024).
Nassiri, N., Cacciamani, G. & Gill, I. S. Robotic bladder auto-transplantation in a heart-beating brain-dead human research donor. Eur. Urol. 84, 517–518 (2023).
pubmed: 37393116
doi: 10.1016/j.eururo.2023.06.004
Jubber, I. et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur. Urol. 84, 176–190 (2023).
pubmed: 37198015
doi: 10.1016/j.eururo.2023.03.029
Teoh, J. Y.-C. et al. Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur. Urol. 78, 893–906 (2020).
pubmed: 32972792
doi: 10.1016/j.eururo.2020.09.006
Kamat, A. M. et al. Bladder cancer. Lancet 388, 2796–2810 (2016).
pubmed: 27345655
doi: 10.1016/S0140-6736(16)30512-8
Hautmann, S. et al. Die Zystektomie aus anderer Indikation als dem Blasenkarzinom. Urologe A 43, 172–177 (2004).
pubmed: 14991119
doi: 10.1007/s00120-003-0485-2
Stein, R. et al. Urinary diversion-approaches and consequences. Dtsch. Arztebl. Int. 109, 617–622 (2012).
pubmed: 23093992
pmcid: 3471265
Nieuwenhuijzen, J. A. et al. Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur. Urol. 53, 834–844 (2008).
pubmed: 17904276
doi: 10.1016/j.eururo.2007.09.008
Stein, R. & Rubenwolf, P. Metabolic consequences after urinary diversion. Front. Pediatr. 2, 15 (2014).
pubmed: 24653981
pmcid: 3948084
doi: 10.3389/fped.2014.00015
Chang, S. S., Alberts, G. L., Smith, J. A. J. & Cookson, M. S. Ileal conduit urinary diversion in patients with previous history of abdominal/pelvic irradiation. World J. Urol. 22, 272–276 (2004).
pubmed: 15448995
doi: 10.1007/s00345-004-0446-4
Atala, A. Engineering tissues, organs and cells. J. Tissue Eng. Regen. Med. 1, 83–96 (2007).
pubmed: 18038397
doi: 10.1002/term.18
Pokrywczynska, M., Adamowicz, J., Sharma, A. K. & Drewa, T. Human urinary bladder regeneration through tissue engineering — an analysis of 131 clinical cases. Exp. Biol. Med. 239, 264–271 (2014).
doi: 10.1177/1535370213517615
Gilding, D. K. & Reed, A. M. Biodegradable polymers for use in surgery — polyglycolic/poly(actic acid) homo- and copolymers: 1. Polymer 20, 1459–1464 (1979).
doi: 10.1016/0032-3861(79)90009-0
Atala, A. Recent applications of regenerative medicine to urologic structures and related tissues. Curr. Opin. Urol. 16, 305–309 (2006).
pubmed: 16770133
doi: 10.1097/01.mou.0000232055.20084.f6
Tsulukidze, A., Murvanidze, D., Dvali, R. & Ivashchenko, G. Formation of a “Bladder” by a plastic shell after total cystectomy. Br. J. Urol. 36, 102–105 (1964).
pubmed: 14126062
doi: 10.1111/j.1464-410X.1964.tb09488.x
Sanchez, R. P. et al. Vesical regeneration in the human after total cystectomy and implantation of a plastic mould. Br. J. Urol. 30, 180–188 (1958).
doi: 10.1111/j.1464-410X.1958.tb06231.x
Atala, A., Bauer, S. B., Soker, S., Yoo, J. J. & Retik, A. B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367, 1241–1246 (2006).
pubmed: 16631879
doi: 10.1016/S0140-6736(06)68438-9
Joseph, D. B., Borer, J. G., De Filippo, R. E., Hodges, S. J. & McLorie, G. A. Autologous cell seeded biodegradable scaffold for augmentation cystoplasty: phase II study in children and adolescents with spina bifida. J. Urol. 191, 1389–1395 (2014).
pubmed: 24184366
doi: 10.1016/j.juro.2013.10.103
Adamowicz, J., Kuffel, B., Van Breda, S. V., Pokrwczynska, M. & Drewa, T. Reconstructive urology and tissue engineering: converging developmental paths. J. Tissue Eng. Regen. Med. 13, 522–533 (2019).
pubmed: 30658008
doi: 10.1002/term.2812
Adamowicz, J., Kloskowski, T., Tworkiewicz, J., Pokrywczyńska, M. & Drewa, T. Urine is a highly cytotoxic agent: does it influence stem cell therapies in urology? Transpl. Proc. 44, 1439–1441 (2012).
doi: 10.1016/j.transproceed.2012.01.128
Pokrywczynska, M. et al. Urinary bladder augmentation with acellular biologic scaffold — a preclinical study in a large animal model. J. Biomed. Mater. Res. B Appl. Biomater. 110, 438–449 (2022).
pubmed: 34323358
doi: 10.1002/jbm.b.34920
Fowler, C. J., Griffiths, D. & de Groat, W. C. The neural control of micturition. Nat. Rev. Neurosci. 9, 453–466 (2008).
pubmed: 18490916
pmcid: 2897743
doi: 10.1038/nrn2401
Andersson, K.-E. & Arner, A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol. Rev. 84, 935–986 (2004).
pubmed: 15269341
doi: 10.1152/physrev.00038.2003
De Groat, W. C. & Kruse, M. N. Central processing and morphological plasticity in lumbosacral afferent pathways from the lower urinary tract. Pain Res. Clin. Manag. 9, 219–235 (1993).
Middleton, J. W. & Keast, J. R. Artificial autonomic reflexes: using functional electrical stimulation to mimic bladder reflexes after injury or disease. Auton. Neurosci. 113, 3–15 (2004).
pubmed: 15296790
doi: 10.1016/j.autneu.2004.04.008
Arena, S. et al. Physiopathology of vesico-ureteral reflux. Ital. J. Pediatr. 42, 103 (2016).
pubmed: 27899160
pmcid: 5129198
doi: 10.1186/s13052-016-0316-x
Çetinel, B., Kocjancic, E. & Demirdağ, Ç. Augmentation cystoplasty in neurogenic bladder. Investig. Clin. Urol. 57, 316 (2016).
pubmed: 27617312
pmcid: 5017553
doi: 10.4111/icu.2016.57.5.316
Takenaka, A. Current status of robot-assisted radical cystectomy: what is the real benefit? Yonago Acta Med. 58, 95–99 (2015).
pubmed: 26538795
pmcid: 4626354
Sylvester, R. J. et al. European Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel. Eur. Urol. 79, 480–488 (2021).
pubmed: 33419683
doi: 10.1016/j.eururo.2020.12.033
Shinagare, A. B. et al. Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor. AJR Am. J. Roentgenol. 196, 117–122 (2011).
pubmed: 21178055
doi: 10.2214/AJR.10.5036
Gallagher, M. P. et al. Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J. Am. Soc. Nephrol. 21, 852–858 (2010).
pubmed: 20431040
pmcid: 2865745
doi: 10.1681/ASN.2009101043
Xu, T. et al. Distant metastasis without regional progression in non-muscle invasive bladder cancer: case report and pooled analysis of literature. World J. Surg. Oncol. 20, 226 (2022).
pubmed: 35794571
pmcid: 9258151
doi: 10.1186/s12957-022-02664-5
Jiang, H., Gu, X., Zuo, Z., Tian, G. & Liu, J. Prognostic value of circulating tumor cells in patients with bladder cancer: a meta-analysis. PLoS ONE 16, e0254433 (2021).
pubmed: 34242363
pmcid: 8270423
doi: 10.1371/journal.pone.0254433
Yan, L., Chen, P., Chen, E.-Z., Gu, A. & Jiang, Z.-Y. Risk of bladder cancer in renal transplant recipients: a meta-analysis. Br. J. Cancer 110, 1871–1877 (2014).
pubmed: 24496458
pmcid: 3974078
doi: 10.1038/bjc.2014.44
Chorbińska, J., Krajewski, W. & Zdrojowy, R. Urological complications after radiation therapy-nothing ventured, nothing gained: a narrative review. Transl. Cancer Res. 10, 1096–1118 (2021).
pubmed: 35116437
pmcid: 8798528
doi: 10.21037/tcr-20-2589
Powell, C. R. Not all neurogenic bladders are the same: a proposal for a new neurogenic bladder classification system. Transl. Androl. Urol. 5, 12–21 (2016).
pubmed: 26904408
pmcid: 4739982
Tarcan, T. et al. Is 40 cm H
pubmed: 27080436
doi: 10.1002/nau.23017
McGuire, E. J., Woodside, J. R., Borden, T. A. & Weiss, R. M. Prognostic value of urodynamic testing in myelodysplastic patients. J. Urol. 126, 205–209 (1981).
pubmed: 7196460
doi: 10.1016/S0022-5347(17)54449-3
Ginsberg, D. A. et al. The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: treatment and follow-up. J. Urol. 206, 1106–1113 (2021).
pubmed: 34495688
doi: 10.1097/JU.0000000000002239
Chong, J. T., Dolat, M. T., Klausner, A. P., Dragoescu, E. & Hampton, L. J. The role of cystectomy for non-malignant bladder conditions: a review. Can. J. Urol. 21, 7433–7441 (2014).
pubmed: 25347367
Kavanagh, A. et al. Canadian Urological Association guideline: diagnosis, management, and surveillance of neurogenic lower urinary tract dysfunction — executive summary. Can. Urol. Assoc. J. 13, 156–165 (2019).
pubmed: 31199234
pmcid: 6570601
Schuind, F., Abramowicz, D. & Schneeberger, S. Hand transplantation: the state-of-the-art. J. Hand Surg. Eur. Vol. 32, 2–17 (2007).
pubmed: 17084950
doi: 10.1016/j.jhsb.2006.09.008
König, P. [Living kidney donation-selection criteria, preparation and follow-up]. Acta Med. Austriaca 28, 70–73 (2001).
pubmed: 11475104
doi: 10.1046/j.1563-2571.2001.01016.x
Banegas, R. N., Moreno, R., Duggal, A. & Breidenbach, W. C. 3rd Surgical aspects of donor hand recovery for transplantation. J. Reconstr. Microsurg. 28, 21–26 (2012).
pubmed: 21861253
doi: 10.1055/s-0031-1285824
Aflaki, P., Nelson, C., Balas, B. & Pomahac, B. Simulated central face transplantation: age consideration in matching donors and recipients. J. Plast. Reconstr. Aesthet. Surg. 63, e283–e285 (2010).
pubmed: 19748842
doi: 10.1016/j.bjps.2009.08.013
Anwar, A. S. M. T. & Lee, J.-M. Medical management of brain-dead organ donors. Acute Crit. Care 34, 14–29 (2019).
pubmed: 31723901
pmcid: 6849043
doi: 10.4266/acc.2019.00430
Rahmel, A. Vascularized composite allografts: procurement, allocation, and implementation. Curr. Transpl. Rep. 1, 173–182 (2014).
pubmed: 25927020
doi: 10.1007/s40472-014-0025-6
Nima, N., Giovanni, C. & Gill, I. S. Robotic bladder autotransplantation: preclinical studies in preparation for first-in-human bladder transplant. J. Urol. 210, 600–610 (2023).
doi: 10.1097/JU.0000000000003620
Konertz, W. [Orthotopic and heterotopic heart transplantation]. Z. Kardiol. 85, 69–73 (1996).
pubmed: 9027109
Jundziłł, A. et al. A new heterotropic vascularized model of total urinary bladder transplantation in a rat model. Sci. Rep. 11, 3775 (2021).
pubmed: 33580157
pmcid: 7881011
doi: 10.1038/s41598-021-83128-w
Suttle, T., Fumo, D., Baghmanli, Z., Saltzman, B. & Ortiz, J. Comparison of urologic complications between ureteroneocystostomy and ureteroureterostomy in renal transplant: a meta-analysis. Exp. Clin. Transpl. 14, 276–281 (2016).
Drakopoulos, S. et al. Transplantation of pediatric kidneys to adult recipients: an analysis of 13 cases. Transpl. Proc. 36, 3161–3163 (2004).
doi: 10.1016/j.transproceed.2004.10.055
Dogan, M. et al. En-bloc pediatric kidney transplantation together with a partial bladder segment: a case report. Pediatr. Nephrol. 26, 805–807 (2011).
pubmed: 21212986
doi: 10.1007/s00467-010-1743-3
Minervini, A. et al. Current indications and results of orthotopic ileal neobladder for bladder cancer. Expert Rev. Anticancer Ther. 14, 419–430 (2014).
pubmed: 24483953
doi: 10.1586/14737140.2014.867235
Thüroff, J. W., Hampel, C., Leicht, W., Gheith, M. K. & Stein, R. [Indications for different types of urinary diversion]. Urologe A 51, 473–476 (2012).
pubmed: 22419009
doi: 10.1007/s00120-012-2811-z
Park, D. S. & Fishman, G. I. Development and function of the cardiac conduction system in health and disease. J. Cardiovasc. Dev. Dis. 4, 7 (2017).
pubmed: 29098150
pmcid: 5663314
Eastham, J. E. & Gillespie, J. I. The concept of peripheral modulation of bladder sensation. Organogenesis 9, 224–233 (2013).
pubmed: 23917648
pmcid: 3896594
doi: 10.4161/org.25895
Adamowicz, J. et al. Schwann cells — a new hope in tissue engineered urinary bladder innervation. A method of cell isolation. Cent. Eur. J. Urol. 64, 87–89 (2011).
doi: 10.5173/ceju.2011.02.art8
Ban, J. et al. Embryonic stem cell-derived neurons form functional networks in vitro. Stem Cell 25, 738–749 (2007).
doi: 10.1634/stemcells.2006-0246
Ma, W. et al. CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels. Exp. Neurol. 190, 276–288 (2004).
pubmed: 15530869
doi: 10.1016/j.expneurol.2003.10.016
Drewa, T., Adamowicz, J., Lysik, J., Polaczek, J. & Pielichowski, J. Chitosan scaffold enhances nerve regeneration within the in vitro reconstructed bladder wall: an animal study. Urol. Int. 81, 330–334 (2008).
pubmed: 18931553
doi: 10.1159/000151414
Adamowicz, J. et al. Development of a conductive biocomposite combining graphene and amniotic membrane for replacement of the neuronal network of tissue-engineered urinary bladder. Sci. Rep. 10, 1–15 (2020).
doi: 10.1038/s41598-020-62197-3
Ławkowska, K. et al. Application of graphene in tissue engineering of the nervous system. Int. J. Mol. Sci. 23, 33 (2021).
pubmed: 35008456
pmcid: 8745025
doi: 10.3390/ijms23010033
Howsare, M., Jones, C. M. & Ramirez, A. M. Immunosuppression maintenance in vascularized composite allotransplantation: what is just right? Curr. Opin. Organ Transpl. 22, 463–469 (2017).
doi: 10.1097/MOT.0000000000000456
Moris, D. & Cendales, L. C. Sensitization and desensitization in vascularized composite allotransplantation. Front. Immunol. 12, 682180 (2021).
pubmed: 34456906
pmcid: 8385557
doi: 10.3389/fimmu.2021.682180
Knoedler, L. et al. Cellular activation pathways and interaction networks in vascularized composite allotransplantation. Front. Immunol. 14, 1179355 (2023).
pubmed: 37266446
pmcid: 10230044
doi: 10.3389/fimmu.2023.1179355
Ng, Z. Y. et al. Graft vasculopathy of vascularized composite allografts in humans: a literature review and retrospective study. Transpl. Int. 32, 831–838 (2019).
pubmed: 30829423
doi: 10.1111/tri.13421
Libretti, S. & Aeddula, N. R. Embryology, genitourinary (StatPearls, 2024).
Fischer, S. et al. Acute rejection in vascularized composite allotransplantation. Curr. Opin. Organ Transpl. 19, 531–544 (2014).
doi: 10.1097/MOT.0000000000000140
Schneeberger, S. et al. Achievements and challenges in composite tissue allotransplantation. Transpl. Int. 24, 760–769 (2011).
pubmed: 21554424
doi: 10.1111/j.1432-2277.2011.01261.x
Brännström, M. et al. Livebirth after uterus transplantation. Lancet 385, 607–616 (2015).
pubmed: 25301505
doi: 10.1016/S0140-6736(14)61728-1
Kueckelhaus, M. et al. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration. Transpl. Int. 29, 655–662 (2016).
pubmed: 26265179
doi: 10.1111/tri.12652
Uluer, M. C. et al. Vascularized composite allotransplantation: medical complications. Curr. Transpl. Rep. 3, 395–403 (2016).
pubmed: 32288984
doi: 10.1007/s40472-016-0113-x
Cendales, L. et al. Tacrolimus to belatacept conversion following hand transplantation: a case report. Am. J. Transpl. 15, 2250–2255 (2015).
doi: 10.1111/ajt.13217
Cendales, L. C. et al. De novo belatacept in clinical vascularized composite allotransplantation. Am. J. Transpl. 18, 1804–1809 (2018).
doi: 10.1111/ajt.14910
Grahammer, J. et al. Benefits and limitations of belatacept in 4 hand-transplanted patients. Am. J. Transpl. 17, 3228–3235 (2017).
doi: 10.1111/ajt.14440
Vincenti, F. et al. Belatacept and long-term outcomes in kidney transplantation. N. Engl. J. Med. 374, 333–343 (2016).
pubmed: 26816011
doi: 10.1056/NEJMoa1506027
Atia, A. et al. Th17 cell inhibition in a costimulation blockade-based regimen for vascularized composite allotransplantation using a nonhuman primate model. Transpl. Int. 33, 1294–1301 (2020).
pubmed: 32277724
doi: 10.1111/tri.13612
Lee, W. P. et al. Relative antigenicity of components of a vascularized limb allograft. Plast. Reconstr. Surg. 87, 401–411 (1991).
pubmed: 1998012
doi: 10.1097/00006534-199103000-00001
Landin, L. et al. Outcomes with respect to disabilities of the upper limb after hand allograft transplantation: a systematic review. Transpl. Int. 25, 424–432 (2012).
pubmed: 22332605
doi: 10.1111/j.1432-2277.2012.01433.x
Schneeberger, S., Morelon, E. & Landin, L. Vascularized composite allotransplantation: a member of the transplant family? Transplantation 93, 1088–1091 (2012).
pubmed: 22592888
doi: 10.1097/TP.0b013e318254ad8a
Chong, T. & Pruett, T. L. Evolution of face transplant: an argument for a national donor registry. Plast. Reconstr. Surg. 132, 1370–1372 (2013).
pubmed: 24165618
doi: 10.1097/PRS.0b013e3182a489dd
Hautmann, R. E. et al. Functional outcome and complications following ileal neobladder reconstruction in male patients without tumor recurrence. more than 35 years of experience from a single center. J. Urol. 205, 174–182 (2021).
pubmed: 32856988
Beecken, W.-D. et al. Robotic-assisted laparoscopic radical cystectomy and intra-abdominal formation of an orthotopic ileal neobladder. Eur. Urol. 44, 337–339 (2003).
pubmed: 12932932
doi: 10.1016/S0302-2838(03)00301-4
Zhou, Q., Chen, X., Chen, Q. & Hao, L. Factors influencing quality of life and functional outcomes in patients with bladder cancer. Cancer Control 30, 10732748231212353 (2023).
pubmed: 37907433
pmcid: 10621294
doi: 10.1177/10732748231212353
Otaola-Arca, H., Seetharam Bhat, K. R., Patel, V. R., Moschovas, M. C. & Orvieto, M. Totally intracorporeal robot-assisted urinary diversion for bladder cancer (part 2). Review and detailed characterization of the existing intracorporeal orthotopic ileal neobladder. Asian J. Urol. 8, 63–80 (2021).
pubmed: 33569273
doi: 10.1016/j.ajur.2020.05.013
Khorrami, M. H. et al. Efficacy of long-acting octreotide on reducing mucus production in patients with ileal neobladder. Clin. Genitourin. Cancer 15, e9–e13 (2017).
pubmed: 27894777
doi: 10.1016/j.clgc.2016.10.012
Vasdev, N., Moon, A. & Thorpe, A. C. Metabolic complications of urinary intestinal diversion. Indian J. Urol. 29, 310–315 (2013).
pubmed: 24235793
pmcid: 3822347
doi: 10.4103/0970-1591.120112